Clindamycin Phosphate; Benzoyl Peroxide Gel shortage

To Be Discontinued

Clindamycin Phosphate; Benzoyl Peroxide Gel is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.

Therapeutic category

Dermatology

Dosage form

Gel

Routes

TOPICAL

Last updated

08/01/2025

Strength variants

Not specified

Need sourcing help for Clindamycin Phosphate; Benzoyl Peroxide Gel?

Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.

Connect with a sourcing partner

Manufacturers reporting shortage

Teva Pharmaceuticals USA, Inc.800-545-8800
To Be Discontinued

Reason for shortage

Not specified

ad slot 300x250

Related shortages in Dermatology

Dexamethasone Sodium Phosphate Injection

Currently in Shortage

Category: Dermatology
Reason: Not specified
Updated: 04/08/2026

Dexamethasone Sodium Phosphate Injection

Currently in Shortage

Category: Dermatology
Reason: Not specified
Updated: 04/03/2026

Dexamethasone Sodium Phosphate Injection

Currently in Shortage

Category: Dermatology
Reason: Not specified
Updated: 04/03/2026

Dexamethasone Sodium Phosphate Injection

Currently in Shortage

Category: Dermatology
Reason: Not specified
Updated: 04/03/2026

Dexamethasone Sodium Phosphate Injection

Currently in Shortage

Category: Dermatology
Reason: Not specified
Updated: 04/03/2026

Dexamethasone Sodium Phosphate Injection

Currently in Shortage

Category: Dermatology
Reason: Not specified
Updated: 04/02/2026

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.